Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy - Gibson, C. Michael; Pinto, Duane S.; Chi, Gerald; Arbetter, Douglas; Yee, Megan; Mehran, Roxana; Bode, Christoph; Halperin, Jonathan; Verheugt, Freek W.A.; Wildgoose, Peter; Burton, Paul; van Eickels, Martin; et al. (Circulation (New York, N.Y.), 2017)
Keywords: Aged; Atrial Fibrillation - drug therapy; Factor Xa Inhibitors - administration & dosage; Factor Xa Inhibitors - therapeutic use; Female; Hospitalization; Humans; Male; Original s; Rivaroxaban - administration & dosage; Rivaroxaban - therapeutic use; Stents - statistics & numerical data; Treatment Outcome; Vitamin K - antagonists & inhibitors; Vitamin K - therapeutic use; atrial fibrillation; percutaneous coronary intervention; rivaroxaban; vitamin K